Search results
Results from the WOW.Com Content Network
Mitsubishi's North American R&D facility in Ann Arbor, Michigan in 2010 2015 was a record setting year for MMNA, selling five million vehicles to date and 95,342 for the year in the United States, continuing a streak of 22 consecutive months of year-over-year sales increases and a 23 percent sales increase over the previous year.
The Mitsubishi 4B4 engine is the newest all-alloy inline four-cylinder engines from Mitsubishi Motors, based on the 4A9 engine from 2004. But in terms of performance ...
Super Shift transmission levers in a Mitsubishi Cordia. The Super Shift transmission, also marketed as Twin-Stick, was a manual transaxle transmission developed by Mitsubishi Motors in the late 1970s and used in a limited number of the company's road cars, most of which were manufactured in the 1980s. It was unusual in that it had 8 forward ...
The Mitsubishi 4M4 engine is a range of four-cylinder diesel piston engines from Mitsubishi Motors, first introduced in the second generation of their Montero/Pajero/Shogun SUVs. They superseded the previous 4D5 engine family, main differences are enlarged displacements and the utilization of one or two over-head camshafts .
President Donald Trump speaks to reporters after landing at Palm Beach International Airport in West Palm Beach, Fla., Sunday, Feb. 16, 2025, after attending the NASCAR Daytona 500 auto race.
Mitsubishi Electric United States, Inc. is the principal subsidiary of Mitsubishi Electric Corporation in the United States. It is headquartered in Cypress, California and was incorporated in 2002 [ 1 ] and its affiliates, have roughly 31 locations throughout North America with approximately 5,000 employees.
The Trump administration sent emails on Saturday evening to U.S. federal government employees telling them to detail their work accomplishments from the previous week by Monday night or risk ...
Thalidomide victim, right; Sen. Kefauver and President-elect Kennedy, 1960 Associated Press and Joun Rous/Associated Press. A key provision of the new law made it a crime for drug companies to promote drugs to doctors for patients with illnesses for which the drug, according to its FDA-approved label, was not intended and approved for use.